We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Devashis Mukherjee, MD, MS

Devashis Mukherjee, MD, MS

  • Specialty: Neonatology
  • Languages Spoken: English, Hindi, Bengali

Biography: Devashis Mukherjee, MD, MS

Titles

  • Clinical Instructor, CWRU School of Medicine
  • Assistant Professor, CWRU School of Medicine

Certifications & Memberships

  • Neonatal/Perinatal Medicine - American Board of Pediatrics
  • Pediatrics - American Board of Pediatrics

Education

Fellowship | Neonatal-Perinatal Medicine
Neonatal-Perinatal Medicine - Medical College Of Wisconsin Affiliated Hospitals, Inc (2018 - 2021)

Residency | Pediatrics
Pediatrics - Beaumont Hospital – Royal Oak Campus (2015 - 2018)

Other Education | Clinical and Translational Science
Clinical and Translational Science - Medical College Of Wisconsin (2021)

Medical Education
Maulana Azad Medical College (2014)

About

Devashis Mukherjee, MD, MS completed his neonatal fellowship at the Medical College of Wisconsin/ Children’s Wisconsin in Milwaukee, WI in 2021. He joined UH Rainbow Babies & Children's as faculty in 2021. Dr. Mukherjee is a basic and translational researcher with a focus on the neonatal innate immune system and its role in Gram negative sepsis. His lab focuses on the transcriptional control of the neutrophil response to bacterial toxin, and how this is related to the increased mortality in preterm babies. He also maintains a biorepository of E. coli isolated from neonates with early and late-onset sepsis in collaboration with other national centers.

Research & Publications

Research Interests

Neonatal innate immune system and its role in Gram negative sepsis

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Devashis Mukherjee did not disclose any Outside Relationships with Industry.